The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Retrospective Evaluation of Commercial Spacers in Prostate Cancer Patients
Official Title: Evaluation of Commercially Available Implantable Spacers, in Prostate Cancer Patients Undergoing Radiotherapy
Study ID: NCT05354427
Brief Summary: Assessment of efficacy and safety of implantable spacers when used to reduce the radiation dose delivered to the organs at risk in prostate cancer patients undergoing radiotherapy.
Detailed Description: Multi-center, retrospective, observational study for assessment of rectal dose reduction following implantation of the BioProtect Balloon Implant System
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Institute of Maria Skłodowska, Curie (MCMCC), Warsaw, , Poland
Cuf Porto institution, Porto, , Portugal